Quick cholesterol fixes may slash heart attack risk

NCT ID NCT07311941

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether rapidly adjusting cholesterol-lowering medications, based on frequent blood tests, helps heart disease patients reach their LDL cholesterol targets faster. Researchers will enroll 1000 adults with coronary artery disease and monitor their cholesterol levels over a year. The goal is to see if this intensive approach reduces the risk of future heart attacks or strokes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: lipid-lowering medications (statins and other cholesterol drugs)
What this could lead to: If successful, this could show that a more intensive monitoring and treatment approach helps more heart patients reach their cholesterol goals and reduce the risk of future heart attacks or strokes.
What could go wrong: This is a registry study, not a randomized trial, so results may be influenced by patient selection. It focuses on cholesterol levels, not directly on preventing heart events, and the approach may not be feasible in all clinics due to resource needs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME DUE TO ATHEROSCLEROTIC CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome cardiovascular disorder coronary atherosclerosis hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIO VASCULAR DISEASE HYPERLIPIDEMIA

Contacts and locations

Locations

Prince of Wales Hospital
RECRUITING

Shatin, New Terrritories, 999077, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.